It is simply where it is, through lack of news and wider exposure. In terms of sellers, I believe many orders in the sell side have simply expired, so it looks thin (and do not forget there are many investors who were happy to place a sell order at 70s and 80s who bought in at much much lower levels). This might not be a bad thing, if we get some news about the current quarter take up of sales credits and utilisation.
Everyone is waiting for news. The trajectory is good. Moving towards base line net real profitability will be the tipping point. I feel we are close. With these kind of companies, ASX investors simply want to see cash earnings move ahead, then it will move. Every quarter is positive, so I am expecting we will continue on the higher path. We have had a couple of small CR's, which always causes the price to hold back, but I think the client list (land grab), geographic expansion and product enhancements will get us to a point of SP advancement soon.
Still a strong buy and hold for me.
- Forums
- ASX - By Stock
- XF1
- Check this out .....
XF1
xref limited
Add to My Watchlist
3.33%
!
15.5¢

Check this out ....., page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $34.11M |
Open | High | Low | Value | Volume |
15.0¢ | 16.0¢ | 15.0¢ | $30.40K | 194.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4621 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 20803 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4621 | 0.150 |
3 | 96000 | 0.130 |
1 | 500000 | 0.125 |
1 | 50000 | 0.120 |
1 | 28575 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 20803 | 1 |
0.165 | 154551 | 4 |
0.170 | 242000 | 2 |
0.180 | 41059 | 1 |
0.200 | 100000 | 1 |
Last trade - 15.44pm 27/06/2025 (20 minute delay) ? |
Featured News
XF1 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online